1. Home
  2. Benzeneacetic acid, a-[[(2-phenyl-4-quinolinyl)carbonyl]amino]-, methylester, (aR)-

Contact Angene

Tel: +852 8191 6999

Email: [email protected]

Brc1cnc(nc1)C
Pyrimidine, 5-bromo-2-methyl-
CCCP1(=O)OP(=O)(CCC)OP(=O)(O1)CCC
1,3,5,2,4,6-Trioxatriphosphorinane, 2,4,6-tripropyl-, 2,4,6-trioxide
CC1(C)OB(OC1(C)C)B1OC(C(O1)(C)C)(C)C
2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octamethyl-
O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]
Tris(dibenzylideneacetone)dipalladium
C1CCC(CC1)P(C1CCCCC1)C1CCCCC1.Cc1cc(C)c(c(c1)C)N1CCN(C1=[Ru](=Cc1ccccc1)(Cl)Cl)c1c(C)cc(cc1C)C
Ruthenium,[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)(tricyclohexylphosphine)-, (SP-5-41)-

Benzeneacetic acid, a-[[(2-phenyl-4-quinolinyl)carbonyl]amino]-, methylester, (aR)-

COC(=O)[C@@H](c1ccccc1)NC(=O)c1cc(nc2c1cccc2)c1ccccc1 Request for Quotation
Chemical Name: Benzeneacetic acid, a-[[(2-phenyl-4-quinolinyl)carbonyl]amino]-, methylester, (aR)-
CAS Number: 174635-53-1
Product Number: AG001ZUB(AGN-PC-0QAL7A)
Synonyms:
MDL No: MFCD00951240
Molecular Formula: C25H20N2O3
Molecular Weight: 396.4379

Identification/Properties

Computed Properties
Molecular Weight:
396.446g/mol
XLogP3:
4.7
Hydrogen Bond Donor Count:
1
Hydrogen Bond Acceptor Count:
4
Rotatable Bond Count:
6
Exact Mass:
396.147g/mol
Monoisotopic Mass:
396.147g/mol
Topological Polar Surface Area:
68.3A^2
Heavy Atom Count:
30
Formal Charge:
0
Complexity:
583
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
1
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information

NMR Spectrum

Other Analytical Data

Request for Quotation

Customer Feedback

Chemical Structure


SB 218795 is a potent and selective inhibitor utilized in chemical synthesis for the inhibition of c-Jun N-terminal kinase (JNK). This small molecule plays a crucial role in modulating various cellular processes, including inflammation, apoptosis, and cell proliferation. By targeting JNK, SB 218795 can effectively block the signaling pathways associated with these processes, offering researchers a valuable tool for investigating the role of JNK in disease states and cellular dysfunction. In addition to its research applications, SB 218795 has shown promising potential in drug development for conditions such as cancer and neurodegenerative diseases where JNK signaling pathways are implicated. Its high selectivity and efficacy make it a valuable asset in the toolkit of synthetic chemists and biomedical researchers aiming to uncover new therapeutic targets and develop novel treatments.